Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results Full Text
Biota, 08/10/2012
Nabi Biopharmaceuticals announced its second quarter financial results for the three–month period ended June 2012. The Company reported a net loss of $2.7 million, or $0.06 per share, compared to net loss of $4.6 million, or $0.11 per share, for the prior year period.



